Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Revenue

Intellia Therapeutics had revenue of $9.11M in the quarter ending September 30, 2024, a decrease of -24.02%. This brings the company's revenue in the last twelve months to $43.09M, down -16.77% year-over-year. In the year 2023, Intellia Therapeutics had annual revenue of $36.28M, down -30.40%.

• Revenue (ttm): $43.09M
• Revenue Growth: -16.77%
• P/S Ratio: 27.14
• Revenue / Employee: $81,913
• Employees: 526
• Market Cap: 1.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	36.28M	-15.85M	-30.40%
Dec 31, 2022	52.12M	19.07M	57.69%
Dec 31, 2021	33.05M	-24.94M	-43.01%
Dec 31, 2020	57.99M	14.89M	34.55%
Dec 31, 2019	43.10M	12.67M	41.63%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.